GSK3145095
| CAS No. | 1622849-43-7 | Cat. No. | BCP31015 |
| Name | GSK3145095 | ||
| Synonyms | GSK-3145095; GSK 3145095; | ||
| Formula | C20H17F2N5O2 | M. Wt | 397.38 |
| Description | GSK3145095 is a potent and orally active RIPK1 inhibitor (IC50 = 5 nM) with potential antineoplastic and immunomodulatory activities. GSK3145095 disrupts RIPK1-mediated signaling, which may reduce C-X-C motif chemokine ligand 1 (CXCL1)-driven recruitment and migration of immunosuppressive myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment (TME). This allows effector cells, such as natural killer (NK) cells and cytotoxic T lymphocytes (CTLs), to kill and eliminate cancer cells. | ||
| Pathways | Apoptosis Pathway | ||
| Targets | RIP | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.